Literature DB >> 28463898

Glucose kinetics: an update and novel insights into its regulation by glucagon and GLP-1.

Amalia Gastaldelli1, Melania Gaggini, Ralph DeFronzo.   

Abstract

PURPOSE OF REVIEW: Glucagon and GLP-1 share the same origin (i.e., proglucagon); primarily GLP-1 is generated from intestinal L-cells and glucagon from pancreatic α-cell, but intestinal glucagon and pancreatic GLP-1 secretion is likely. Glucose kinetics are tightly regulated by pancreatic hormones insulin and glucagon, but other hormones, including glucagon-like peptide-1 (GLP-1), also play an important role. The purpose of this review is to describe the recent findings on the mechanisms by which these two hormones regulate glucose kinetics. RECENT
FINDINGS: Recent findings showed new important mechanisms of action of glucagon and GLP-1 in the regulation of glucose metabolism. Knock out of glucagon receptors protects against hyperglycemia without causing hypoglycemia. GLP-1 not only stimulates insulin secretion, but it has also an independent effect on the liver and inhibits glucose production. Moreover, when coinfused with glucagon, GLP-1 limits the hyperglycemic effects. Both hormones have also central effects on gastric emptying (delayed), intestinal motility (reduced), and satiety (increased).
SUMMARY: The implications of these findings are very important for the management of type 2 diabetes given that GLP-1 receptor agonist are currently approved for the treatment of hyperglycemia and glucagon receptor antagonists and GLP-1/glucagon dual agonists are under development.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28463898     DOI: 10.1097/MCO.0000000000000384

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  5 in total

Review 1.  Bidirectional Relationship between Gastric Emptying and Plasma Glucose Control in Normoglycemic Individuals and Diabetic Patients.

Authors:  Bogdan Mircea Mihai; Cătălina Mihai; Cristina Cijevschi-Prelipcean; Elena-Daniela Grigorescu; Mihaela Dranga; Vasile Drug; Ioan Sporea; Cristina Mihaela Lăcătușu
Journal:  J Diabetes Res       Date:  2018-10-03       Impact factor: 4.011

2.  Effectiveness of Eriomin® in managing hyperglycemia and reversal of prediabetes condition: A double-blind, randomized, controlled study.

Authors:  Carolina B Ribeiro; Fernanda M Ramos; John A Manthey; Thais B Cesar
Journal:  Phytother Res       Date:  2019-06-11       Impact factor: 5.878

Review 3.  Effects of the Treatment with Flavonoids on Metabolic Syndrome Components in Humans: A Systematic Review Focusing on Mechanisms of Action.

Authors:  Henrique J C B Gouveia; Mercedes V Urquiza-Martínez; Raul Manhães-de-Castro; Bárbara J R Costa-de-Santana; José Pérez Villarreal; Rosalío Mercado-Camargo; Luz Torner; Jailane de Souza Aquino; Ana E Toscano; Omar Guzmán-Quevedo
Journal:  Int J Mol Sci       Date:  2022-07-28       Impact factor: 6.208

4.  Subcutaneous adipose tissue composition and function are unaffected by liraglutide-induced weight loss in adults with type 1 diabetes.

Authors:  Anne-Marie Wegeberg; Theresa Meldgaard; Amanda Baek; Asbjørn Mohr Drewes; Mogens Vyberg; Niels Jessen; Birgitte Brock; Christina Brock
Journal:  Basic Clin Pharmacol Toxicol       Date:  2021-03-05       Impact factor: 4.080

5.  Anti-hyperglycemic and anti-hyperlipidemia effects of the alkaloid-rich extract from barks of Litsea glutinosa in ob/ob mice.

Authors:  Xiaopo Zhang; Yan Jin; Younan Wu; Caiyun Zhang; Dejun Jin; Qingxia Zheng; Youbin Li
Journal:  Sci Rep       Date:  2018-08-23       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.